small ruminants
  • Blog
  • Videos
  • About us
  • Contact us
  • Subscribe
  • English
    • Français
    • Italiano
    • Español
    • Ελληνικα
  • Blog
  • Videos
  • About us
  • Contact us
  • Subscribe
  • English
    • Français
    • Italiano
    • Español
    • Ελληνικα

WHERE DO THE COSTS OWING TO MASTITIS ORIGINATE FROM?

  • November 16, 2020
Facebook
Twitter
LinkedIn
It is always said that mastitis is the most expensive disease on a dairy farm. Nonetheless, do we really know the economic impact of mastitis on the farm? Being aware of what this disease costs us and taking measures to control it is paramount, not only for the profitability of the farm, but also for the welfare of the animals and ourselves!

 

Visible costs

The most obvious losses are caused by clinical mastitis. In sheep and goats, this type of mastitis tends to occur during the first 3 months of lactation and is usually acute.

This leads to high production losses (falls in production in excess of 70%) and a high number of casualties, as mastitis is rarely treatable and usually results in the death or slaughter of the animal.

However, as sub-clinical mastitis is much more common, it is important not to disregard the costs that this will cause. In this case, the main cost stems from a decrease in production, which on average falls by 13% (Martí de Olives et al.).

“Clinical mastitis leads to a drop in production of more than 70% and usually results in the death or slaughter of the animal”

Somatic cells help to give us an idea of the losses incurred as a result of mastitis. In the case of goats, the curve in the graph in Figure 1 and Table 1 (Pleguezuelos at al.) show that production drops by more than 11% in goats with 1 million cells, and by almost 20% in goats with 2 million cells.

Figure 1: Relationship between somatic cells and production in goats per month of lactation. The greater the number of somatic cells, the lower the production.
SOMATIC CELL COUNT SHEEP GOATS
1.000.000 -14,1% -11,4%
2.000.000 -21,1% -19,5%
3.000.000 -25,20% -24,2%

Table 1. Estimation of production losses in sheep and goats according to somatic cell count.

According to Gonzalo et al., the situation is similar in sheep, as shown in Table 1 and Figure 2. Production can drop by more than 14% in ewes with over one million somatic cells, and by more than 20% in ewes with more than 2 million cells.

Figure 2: Evolution of annual milk production (l/ewe / year) according to individual cell count.

Hidden costs

This lower production from sub-clinically infected animals means that they have to be replaced earlier than expected, thus increasing the replacement rate.

Sub-clinical mastitis in sheep and goats: California mastitis test (CMT)
Figure 3: The California mastitis test (CMT) is used to instantly assess the presence of sub-clinical mastitis in sheep and goats.

Moreover, it gives rise to poorer quality milk with a higher somatic cell count, a greater bacteriological count and an imbalance in the composition of protein and fat (Leitner et al). These modifications involve penalties in the payment of milk in most countries and also affect the growth of lambs and kids. Lambs born from infected mothers will take longer to grow (Moroni et al.)

“Mastitis causes changes in the quality and composition of milk, resulting in penalties and significantly reduced growth in lambs and kids”

The replacement of all animals with abnormalities is one of the highest costs of mastitis.
Finally, the labour costs, the treatments required on some occasions and the discarding of milk in the event of treatment all contribute to the total losses caused by this disease.

Figure 4: Losses due to reduced production and the increase in replacements are the factors that have the greatest economic impact.

Mean cost

“The cost of each case of clinical mastitis exceeds €300; the cost per sheep or goat with sub-clinical mastitis is in the region of €80”

The cost of mastitis in dairy sheep or goats exceeds €300 per case, while one case of sub-clinical mastitis may be around €80. The cost for one farm usually exceeds €50 euros on average per animal on the farm.
It is therefore essential to implement a mastitis control programme that combines management measures with vaccination.

Previous Post

RESPIRATORY PROBLEMS: just another problem or something more serious?

Next Post

PAST, PRESENT AND FUTURE OF CHLAMYDIA VACCINES

Related Posts

How can we calculate the profitability of vaccination against abortions?

Key points for the diagnosis of 𝘊. 𝘢𝘣𝘰𝘳𝘵𝘶𝘴: act quickly to effectively control it

October 21, 2025

Transmission of pathogens during milking is the main cause of mastitis in small ruminants. Improper use or malfunction of milking...

Impact Of Vaccination Against Mastitis In Primiparous Goats: A Study In The Netherlands

Beyond health: the economic impact of resistance

September 14, 2025

Transmission of pathogens during milking is the main cause of mastitis in small ruminants. Improper use or malfunction of milking...

CATEGORIES

  • Antibiotic reduction
  • Field experience
  • Footrot
  • Mastitis
  • Other Goats, Sheep and Lamb Diseases
  • Reproductive
  • Respiratory

NEWSLETTER

DON’T MISS ANY UPDATES ON SMALL RUMINANTS

    I have read and agree to the Privacy Policy and Basic information on Data Protection.

    ASK THE EXPERTS

    Your opinion is very important to us, so we encourage you to contact our team of experts on Small Ruminants to ask any questions or discuss any concerns you may have about sheep, goats and lambs health prevention.

      I have read and agree to the Privacy Policy and Basic information on Data Protection.

      Next Post
      Chlamydia vaccines for sheep & goats: in-depth analysis of these vaccines

      PAST, PRESENT AND FUTURE OF CHLAMYDIA VACCINES

      small ruminants

      Follow us

      Linkedin Youtube
      Categories
      • Antibiotic reduction
      • Field experience
      • Footrot
      • Mastitis
      • Other Goats, Sheep and Lamb Diseases
      • Reproductive
      • Respiratory

      Pages

      • Blog
      • Videos
      • About us
      • Contact

      HIPRA ©2025 All rights reserved

      • Cookie policy
      • Terms of use
      • Privacy policy
      • Cookie policy
      • Terms of use
      • Privacy policy

      Mastitis control program

      Our 6-point mastitis control program is a set of structured measures and practices, validated to improve udder health and milk quality in dairy farms.



        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our
        Privacy Policy.

        For further information, please check our detailed information on Data Protection.
        close-link
        Powered by Convert Plus

        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

        For further information, please check our detailed information on Data Protection.

        Website for veterinarians

        The contents of this website are aimed exclusively at prescribing veterinarians. By clicking on Accept you state that you are a veterinary professional. In other case, please contact a veterinarian and click on Decline.

        ACCEPT
        DECLINE

        NEWSLETTER

        Don´t miss any updates

          I have read and agree to the Privacy Policy and Basic information on Data Protection.

          Informazioni di base sulla protezione dei dati personali:

          Titolare del trattamento: LABORATORIOS HIPRA, S.A.
          Finalità: Gestione del rapporto contrattuale e/o commerciale con HIPRA, incluso l’invio di notizie, promozioni e inviti a eventi sponsorizzati da HIPRA.
          Base giuridica: Esecuzione del rapporto contrattuale e del legittimo interesse di HIPRA.
          Destinatari: Terzi a cui HIPRA ha affidato servizi di cloud computing, sicurezza, auditing, mailing, supporto tecnico e informatico, nonché società del suo gruppo.
          Diritti: Richiedere l'accesso e la rettifica o la cancellazione dei dati personali e altri diritti come spiegato nelle informazioni aggiuntive. Puoi vedere le informazioni aggiuntive dettagliate sulla protezione dei dati nella nostra Informativa sulla privacy.

          Per ulteriori informazioni, puoi consultare le nostre informazioni dettagliate sulla Protezione dei dati.

          Informations de base sur la protection des données personnelles :

          Contrôleur : LABORATORIOS HIPRA, S.A.
          Objectifs : Gérer la relation contractuelle et/ou commerciale avec HIPRA, y compris l'envoi de nouvelles, de promotions et d'invitations à des événements sponsorisés par HIPRA.
          Base légale : Exécution de la relation contractuelle et intérêt légitime d'HIPRA.
          Destinataires : Tiers auxquels HIPRA a confié le cloud computing, la sécurité, l'audit, le mailing, les aspects techniques et informatiques services de support, ainsi que les sociétés de son groupe.
          Droits : demander l'accès et la rectification ou l'effacement des données personnelles et d'autres droits comme expliqué dans les informations supplémentaires. Vous pouvez consulter les informations supplémentaires détaillées sur la protection des données dans notre Politique de confidentialité.

          Pour plus d'informations, veuillez consulter nos informations détaillées sur la protection des données. .

          Βασικές πληροφορίες προστασίας προσωπικών δεδομένων:

          Ελεγκτής: ΕΡΓΑΣΤΗΡΙΟ HIPRA, S.A.
          Σκοποί: Διαχείριση της συμβατικής ή/και επιχειρηματικής σχέσης με την HIPRA, συμπεριλαμβανομένης της αποστολής ειδήσεων, προωθήσεων και προσκλήσεων σε εκδηλώσεις που χρηματοδοτούνται από την HIPRA.
          Νόμιμη βάση: Εκτέλεση της συμβατικής σχέσης και έννομο συμφέρον της HIPRA.
          Παραλήπτες: Τρίτα μέρη στα οποία η HIPRA έχει εμπιστευθεί το cloud computing, την ασφάλεια, τον έλεγχο, την αλληλογραφία, την τεχνική και τον υπολογιστή υπηρεσίες υποστήριξης, καθώς και εταιρείες του ομίλου της.
          Δικαιώματα: Ζητήστε πρόσβαση και διόρθωση ή διαγραφή προσωπικών δεδομένων και άλλων δικαιωμάτων, όπως εξηγείται στις πρόσθετες πληροφορίες. Μπορείτε να δείτε αναλυτικές πρόσθετες πληροφορίες σχετικά με την προστασία δεδομένων στο Πολιτική Απορρήτου.

          Για περισσότερες πληροφορίες, ελέγξτε τις λεπτομερείς πληροφορίες σχετικά με την Προστασία Δεδομένων .

          Información básica sobre protección de datos:

          Responsable del tratamiento: LABORATORIOS HIPRA, S.A.
          Propósitos: Gestionar la relación contractual y comercial con HIPRA, incluido el envío de noticias, promociones e invitaciones a eventos patrocinados por HIPRA.
          Fundamentos legales: Cumplimiento de la relación contractual e interés legítimo de HIPRA.
          Destinatarios: Terceros a los que HIPRA ha encargado las tareas de computación en la nube, seguridad, auditoría, correo, servicios de soporte técnico e informático, así como empresas de su grupo.
          Derechos: Solicitar el acceso y la rectificación o eliminación de los datos personales y otros derechos, tal como se explica en la información adicional. Puede ver la información adicional detallada sobre la protección de datos en nuestra Política de Privacidad.

          Para obtener más información, consulte nuestra información detallada sobre Protección de datos.

          Basic Personal Data Protection information:

          Controller: LABORATORIOS HIPRA, S.A.
          Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
          Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
          Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
          Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

          For further information, please check our detailed information on Data Protection.